Biomarkers in Respiratory Disease: Chronic Obstructive Pulmonary Disease

16 Nov 2016

This white paper highlights a potential application for LGCs Biomarker Testing Service, the monitoring of Chronic Obstructive Pulmonary Disease (COPD). The analysis of disease progression and treatment response in COPD is reliant on the triangulation of biomarkers from three sub-pathologies.

Links

Tags